References
- NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83–90.
- Sánchez-Cruz JJ, Cabrera-León A, Martín-Morales A, et al. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245–253.
- Brooke JC, Walter DJ, Kapoor D, et al. Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes. Andrology. 2014;2(2):205–211.
- Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50–56.
- Laumann EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res. 1999;1:60–64.
- Billups KL. Erectile dysfunction as an early sign of cardiovascular disease. Int J Impot Res. 2005;17:19–24.
- Yassin A, Almehmadi Y, Alwani M, et al. Long-term testosterone therapy improves renal function in men with hypogonadism: a real-life prospective controlled registry. J Clin Nephrol Res. 2020;7:1095.
- Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304.
- Mayumi A, Kumakura S, Kikuchi M. Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients. Ren Fail. 2019;41:47–56.
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
- Akkus E, Kadioglu A, Esen A, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population based study. Eur Urol. 2002;41:298–304.
- Diaconu CC, Manea M, Marcu DR, et al. The erectile dysfunction as a marker of cardiovascular disease: a review. Acta Cardiol. 2020;75:286–292.
- Jones RWA, Rees RW, Minhas S, et al. Oxygen free radicals and the penis. Expert Opin Pharmacother. 2002;3(7):889–897.
- Gorsane I, Amri N, Younsi F, et al. Erectile dysfunction in hemodialysis patients. Saudi J Kidney Dis Transpl. 2016;27:23–28.
- Johnson D, Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Evaluation of renal function. Nephrology (Carlton). 2005;10(s4):S133–S176.
- Serdengeçti K. Turkish Society of Nephrology and World Kidney Day. Turk Nephrol. 2010;19:1–2.
- Abdel-Gawad M, Huynh H, Brock GB. Experimental chronic renal failure-associated erectile dysfunction: molecular alterations in nitric oxide synthase pathway and IGF-I system. Mol Urol. 1999;3(2):117–125.
- Reckelhoff JF, Manning RD Jr. Role of endothelial-derived nitric oxide in the control of the renal microvasculature in aging male rats. Am J Physiol Regul Integr Comp Physiol. 1993;265:1126–1131.
- Rosas SE, Joffe M, Franklin E, et al. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int. 2003;64:232–238.
- Schmidt A, Luger A, Horl WH. Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant. 2002;17(3):368–371.
- Holdsworth S, Atkins RC, de Kretser DM. The pituitary-testicular axis in men with chronic renal failure . N Engl J Med. 1977;296(22):1245–1249.
- Amiri M, Tehrani FR, Rahmati M, et al. Low serum testosterone levels and the incidence of chronic kidney disease among male adults: a prospective population-based study. Andrologia. 2020;8(3):575–582.